Parkman Healthcare Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-176,994
Closed -$20M 92
2024
Q4
$20M Buy
176,994
+53,393
+43% +$6.17M 2.67% 11
2024
Q3
$14.1M Buy
123,601
+1,688
+1% +$185K 1.8% 20
2024
Q2
$12.7M Buy
121,913
+224
+0.2% +$23.8K 1.7% 16
2024
Q1
$13.8M Sell
121,689
-35,038
-22% -$4.02M 1.7% 17
2023
Q4
$17.3M Buy
+156,727
New +$15.7M 2.43% 12

Other funds holding ABT

Parkman Healthcare Partners's ABT Position: Q1 2025 in Review

Parkman Healthcare Partners sold out of Abbott (ABT) in Q1 2025, closing a stake of 176,994 shares — an estimated $20M sold.

Parkman Healthcare Partners first reported a position in ABT in Q4 2023 and held it in 5 quarters. The position peaked at $20M in Q4 2024. 3,169 funds tracked by Wall St. Rank hold ABT as of Q1 2025.

  • Parkman Healthcare Partners reported no remaining Abbott position as of Q1 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 176,994 Abbott shares in Q1 2025, an estimated $20M.
  • Parkman Healthcare Partners first reported a position in Abbott in Q4 2023 and held it in 5 quarters.
  • Parkman Healthcare Partners's Abbott position peaked at $20M in Q4 2024.
  • 3,169 funds tracked by Wall St. Rank held Abbott as of Q1 2025.

Based on Parkman Healthcare Partners's 13F filing for Q1 2025, filed 15 May 2025.